von Willebrand factor genotyping for validation of type 2N von Willebrand disease subtitle: the relation between genotype and phenotype in von Willebrand disease type 2N

被引：0
|
作者：
Mancini, T. [1 ]
Van Haren, B. [1 ]
Schoormans, S. [1 ]
Hofste, T. [1 ]
Diekstra, A. [1 ]
Laros-van Gorkom, B. A. P. [1 ]
Brons, P. [1 ]
Hoefsloot, L. [1 ]
Van Heerde, W. L. [1 ]
机构：
[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [21] Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease
    Favaloro, Emmanuel J.
    THROMBOSIS RESEARCH, 2011, 127 (01) : 2 - 3
  • [22] Hemophilia and von Willebrand disease type 2N in women with inherited coagulopathies
    Miller, CH
    Kelley, L
    Park, AM
    Green, D
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2678 - P2678
  • [23] Identifying carriers of type 2N von Willebrand disease: Procedures and significance
    Casonato, A.
    Pontara, E.
    Sartorello, F.
    Cattini, M. G.
    Perutelli, P.
    Bertomoro, A.
    Gallinaro, L.
    Pagnan, A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (02) : 194 - 200
  • [24] Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa
    Ryu, Justine H.
    Bauer, Kenneth A.
    Schulman, Sol
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (12) : 3508 - 3510
  • [25] Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia
    Favaloro, Emmanuel J.
    Mohammed, Soma
    Koutts, Jerry
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (08) : 706 - 714
  • [26] Evaluation of an automated screening assay for von Willebrand Disease Type 2N
    Taylor, SL
    Bromidge, E
    Savidge, GF
    Alhaq, A
    CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (06): : 369 - 375
  • [27] Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis
    Veyradier, A.
    Caron, C.
    Ternisien, C.
    Wolf, M.
    Trossaert, M.
    Fressinaud, E.
    Goudemand, J.
    HAEMOPHILIA, 2011, 17 (06) : 944 - 951
  • [28] Results of a screening for von Willebrand disease type 2N patients with suspected haemophilia A or van Willebrand disease type 1
    Schneppenheim, R
    Budde, U
    Krey, S
    Drewke, E
    Bergmann, F
    Lechler, E
    Oldenburg, J
    Schwaab, R
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (04) : 598 - 602
  • [29] THE VON WILLEBRAND DISEASE TYPE 2A (IIH): A UNIQUE VARIANT OF VON WILLEBRAND FACTOR DUE TO COMBINED 2A(IIC)/2N DEFECTS
    Punzo, M.
    La Marca, S.
    Rubini, V
    Cozzi, G.
    Canciani, M. T.
    Baronciani, L.
    Mannucci, P. M.
    Federici, A. B.
    HAEMATOLOGICA, 2008, 93 : S115 - S115
  • [30] DDAVP in patients with von Willebrand disease (VWD) type 2N and phenotype compatible with VWD type 2N.
    Casais, P
    Farias, CE
    Meschengieser, SS
    Carballo, GA
    Kempfer, AC
    Grosso, S
    Lazzari, MA
    BLOOD, 2001, 98 (11) : 80B - 80B
12345